ELEVATING DERMATOLOGICAL CARE
Sensus Healthcare FAQ
SUPERFICIAL RADIOTHERAPY
Superficial Radiotherapy (SRT) is a non-invasive treatment technique that uses low-energy radiation to target skin conditions such as non-melanoma skin cancer and keloids. It delivers precise radiation directly to the affected area, minimizing damage to surrounding healthy tissue.
SRT works by delivering targeted radiation to the skin lesion or tumor. This radiation damages the DNA of cancer cells or abnormal tissue, preventing them from multiplying and causing them to die off. SRT is designed to spare nearby healthy tissue, reducing the risk of side effects.
SRT is commonly used to treat non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign conditions like keloids. Your healthcare provider can determine if SRT is suitable for your specific condition.
SRT is generally well-tolerated by patients and is not associated with significant pain. Some individuals may experience mild discomfort during treatment, but this can often be managed with over-the-counter pain relievers.
The duration of an SRT treatment session can vary depending on the size and location of the lesion being treated. Typically, each session lasts two-to-three minutes. Multiple sessions may be required over several weeks for optimal results.
SRT is associated with minimal side effects compared to other treatment options. Some patients may experience temporary skin irritation, redness, or mild itching at the treatment site. These side effects usually resolve on their own within a few weeks.
Unlike surgery, there is typically no downtime associated with SRT. Patients can resume their normal activities immediately after treatment. However, it’s essential to follow any post-treatment care instructions provided by your healthcare provider.
Clinical studies have shown that SRT is highly effective in treating non-melanoma skin cancers, with high cure rates and excellent cosmetic outcomes. Your healthcare provider can provide more information about the expected outcomes for your specific condition.
Coverage for SRT may vary depending on your insurance provider and individual policy. It’s recommended to check with your insurance company to determine coverage eligibility and any potential out-of-pocket costs. SRT is covered by Medicare/Medicaid and most major insurers.
For more information about SRT and to determine if it’s the right treatment option for you, schedule a consultation with a qualified healthcare provider specializing in dermatology or radiation oncology. They can provide personalized recommendations based on your individual needs and condition.
SUPERFICIAL RADIOTHERAPY (SRT)
Superficial Radiotherapy (SRT) is a non-invasive treatment modality that delivers low-energy radiation to target specific skin conditions, including non-melanoma skin cancers and benign lesions including keloids. It offers a precise and effective alternative to surgery or traditional radiation therapy for eligible patients.
Unlike traditional radiation therapy, which uses higher energy radiation to penetrate deeper tissues, SRT delivers low-energy radiation directly to the skin surface. This targeted approach minimizes damage to surrounding healthy tissue, making it ideal for superficial lesions.
SRT is indicated for various dermatologic conditions, including basal cell carcinoma, squamous cell carcinoma, Bowen’s disease, and keloids. It can also be used for the palliative treatment of symptomatic skin metastases.
SRT offers several advantages, including excellent cosmetic outcomes, minimal risk of scarring or functional impairment, high cure rates comparable to surgery, and convenient outpatient treatment. It can be used in challenging anatomical locations and for patients who are poor candidates for surgery or traditional radiation therapy.
SRT is typically delivered using a specialized superficial x-ray beam generated by a dedicated SRT machine. The treatment is administered in a clinical setting by trained healthcare professionals, with the patient positioned comfortably for precise targeting of the affected area.
The treatment course for SRT varies depending on the specific condition being treated and individual patient factors. Generally, patients undergo multiple treatment sessions over several weeks, with each session lasting a few minutes. Treatment schedules and total dose are tailored to optimize outcomes while minimizing side effects.
SRT is associated with minimal acute side effects compared to surgery or traditional radiation therapy. Temporary skin reactions such as erythema, edema, and mild desquamation may occur, but these typically resolve within a few weeks. Long-term side effects such as hypopigmentation or telangiectasia are rare.
Incorporating SRT into your practice requires appropriate training, equipment, and patient selection. Sensus Healthcare provides comprehensive training and support to healthcare providers interested in offering SRT. Our team can assist with equipment installation, clinical education, reimbursement support, and ongoing technical assistance.
Reimbursement for SRT is available through Medicare and most private insurance plans. Sensus Healthcare works with MedIQ who offers assistance with reimbursement coding, documentation, and appeals to ensure optimal reimbursement for eligible patients. MedIQ’s reimbursement team can provide guidance on coding, coverage policies, and documentation requirements.
For more information about SRT and to explore how it can benefit your patients and practice, contact Sensus Healthcare or visit our website. Our team of experts is available to answer any questions, provide clinical support, and facilitate training to help you integrate SRT into your clinical practice successfully.
ELEVATING DERMATOLOGICAL CARE
